Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

9.48
-0.0900-0.94%
Post-market: 9.31-0.1730-1.82%19:53 EDT
Volume:2.82M
Turnover:26.72M
Market Cap:809.33M
PE:-17.05
High:9.78
Open:9.66
Low:9.28
Close:9.57
Loading ...
Feb 07, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 07, 2023

Major Issues Report

8-K - Current report
Jan 27, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 10, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 10, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 27, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 08, 2022

Major Issues Report

8-K - Current report
Mar 04, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 04, 2022

Major Issues Report

8-K - Current report
Feb 02, 2022

Major Issues Report

8-K - Current report
Sep 13, 2021

Major Issues Report

ANAVEX LIFE SCIENCES CORP.
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities